⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12574025 | 0.92 | MEN1 (0.57) | — | |
| SCHEMBL14654943 | 0.91 | MAPT (0.45) | — | |
| SCHEMBL5112007 | 0.90 | TSHR (0.59) | — | |
| SCHEMBL4704528 | 0.87 | HRH3 (0.44) | — | |
| SCHEMBL14652209 | 0.86 | GRM4 (0.43) | — | |
| SCHEMBL29587148 | 0.85 | MEN1 (0.44) | — | |
| SCHEMBL2402987 | 0.85 | KDM4E (0.51) | — | |
| SCHEMBL2402980 | 0.85 | KDM4E (0.51) | — | |
| SCHEMBL2401148 | 0.83 | NPC1 (0.48) | — | |
| SCHEMBL2401153 | 0.83 | NPC1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240383884-A1 | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE | CORVUS PHARMACEUTICALS, INC. | 2024-11-21 | — | — | US | disclosed |
| CN-105143222-B | Glycosidase inhibitor | 默克专利有限公司 | 2018-02-02 | — | — | CN | disclosed |